Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 27, 2026

Microsoft (MSFT) Down 7.3% Since Last Earnings Report: Can It Rebound?

View original at finance.yahoo.com
Microsoft (MSFT) Down 7.3% Since Last Earnings Report: Can It Rebound? It has been about a month since the last earnings report for Microsoft (MSFT)…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Microsoft Cloud revenues totaled $51.5 billion, crossing the $50 billion quarterly threshold for the first time and growing 26% year over year

    80% confidence
  • Microsoft 365 consumer subscriptions expanded to more than 90 million users

    80% confidence
  • Capital expenditure is expected to decrease sequentially in fiscal third quarter due to normal variability from cloud infrastructure buildouts and timing of delivery of finance leases

    80% confidence
  • Microsoft 365 commercial paid seats grew 6% year over year, with installed base expansion occurring across all customer segments, concentrated primarily in small and medium business offerings and frontline worker categories

    80% confidence
  • The company now counts 900 million monthly active users of AI features across its products, with over 150 million monthly active users of first-party Copilots

    80% confidence
  • The company now expects fiscal 2026 operating margins to rise slightly for the full year, aided by first-half investment prioritization and favorable impacts from revenue mix shifts

    80% confidence
  • Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising

    80% confidence
  • Commercial bookings surged 230% (228% in constant currency), significantly exceeding projections, reflecting substantial Azure commitments and expansion in large contracts exceeding $100 million

    80% confidence
  • Azure and other cloud services revenue growth is expected to reach approximately 37-38% in constant currency for Q3 FY2026, as demand continues to significantly exceed available capacity

    80% confidence
  • More than 90% of Fortune 500 organizations now utilize Microsoft 365 Copilot, with major enterprise customers deploying tens of thousands of seats

    80% confidence
  • The company now expects to remain capacity-constrained through at least fiscal year-end, with demand exceeding current infrastructure buildout, resulting in lost revenue opportunities for Azure

    80% confidence
  • Azure AI Foundry now serves a customer base exceeding 80,000 organizations, including 80% of Fortune 500 companies, with access to over 11,000 models

    80% confidence
  • For Q3 FY2026, Intelligent Cloud segment revenues are projected between $32.65-$32.95 billion, suggesting growth of approximately 27-28%

    80% confidence
  • Microsoft has a Zacks Rank #3 (Hold), with expectation of an in-line return from the stock in the next few months

    80% confidence
  • Microsoft Fabric revenues grew 60%, outpacing other data and analytics platforms in the industry, with the customer base expanding to 28,000 paid subscribers

    80% confidence
  • For Q3 FY2026, Productivity and Business Processes segment is expected to generate revenues between $34.25-$34.55 billion, indicating growth of 14-15%

    80% confidence
  • The commercial remaining performance obligation reached $625 billion, marking 110% year-over-year growth, with the balance nearly tripling over a two-year period

    80% confidence

Data points we hold from this source

OpenAI · investment gain7.6 billion_USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com